Evaluation of the relationship between muscle mass and serum myostatin levels in chronic hemodialysis patients

The loss of muscle mass and cachexia is commonly seen in hemodialysis (HD) patients and contribute to morbidity and mortality. The exact mechanism of this fact is multifactorial and still unclear. Myostatin, a transforming growth factor-ß family ligand, is released from the skeletal and heart muscle...

Full description

Bibliographic Details
Main Authors: Derya Koyun, Gokhan Nergizoglu, Kemal Metin Kir
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2018-01-01
Series:Saudi Journal of Kidney Diseases and Transplantation
Online Access:http://www.sjkdt.org/article.asp?issn=1319-2442;year=2018;volume=29;issue=4;spage=809;epage=815;aulast=Koyun
id doaj-01a8822c831f46bab8dc86365224c57d
record_format Article
spelling doaj-01a8822c831f46bab8dc86365224c57d2020-11-24T22:53:30ZengWolters Kluwer Medknow PublicationsSaudi Journal of Kidney Diseases and Transplantation1319-24422018-01-0129480981510.4103/1319-2442.239648Evaluation of the relationship between muscle mass and serum myostatin levels in chronic hemodialysis patientsDerya KoyunGokhan NergizogluKemal Metin KirThe loss of muscle mass and cachexia is commonly seen in hemodialysis (HD) patients and contribute to morbidity and mortality. The exact mechanism of this fact is multifactorial and still unclear. Myostatin, a transforming growth factor-ß family ligand, is released from the skeletal and heart muscle and may be responsible for muscle degradation and atrophy. The aim of this study is evaluation of the relationship between muscle mass and serum myostatin level in chronic HD patients. One hundred and forty HD patients (79 males, 28 diabetic, mean age; 53.96 ± 13.6) were included in this cross-sectional study. Muscle mass measurement was made with dual energy-X ray absorptiometry. Appendicular skeletal muscle index (ASMI) was used as a muscle mass indicator. The anthropometric and biochemistry data were obtained. Serum myostatin levels were determined by an ELISA kit. Serum myostatin levels were elevated when compared to controls (P <0.001), but no significant correlation with ASMI was observed (P = 0.624). ASMI significantly correlated with serum creatinine (P <0.001), creatine phosphokinase (P <0.001), prealbumin (P <0.012), albumin (P <0.039), transferrin (P <0.001), phosphorus (P <0.001), Ca×P (P <0.012), inversely with Kt/V (P <0.001); not with BUN (P = 0.739), parathyroid hormone (P = 0.698), 25-hydroxyvitamin D (P = 0.603), bicarbonate (P = 0.062); such that these parameters also have influence on muscle mass regulation. Our study indicated that myostatin levels were high in HD patients but had no relation with ASMI. Myostatin is a well-known regulator of muscle mass so further studies are needed to demonstrate possible relationship.http://www.sjkdt.org/article.asp?issn=1319-2442;year=2018;volume=29;issue=4;spage=809;epage=815;aulast=Koyun
collection DOAJ
language English
format Article
sources DOAJ
author Derya Koyun
Gokhan Nergizoglu
Kemal Metin Kir
spellingShingle Derya Koyun
Gokhan Nergizoglu
Kemal Metin Kir
Evaluation of the relationship between muscle mass and serum myostatin levels in chronic hemodialysis patients
Saudi Journal of Kidney Diseases and Transplantation
author_facet Derya Koyun
Gokhan Nergizoglu
Kemal Metin Kir
author_sort Derya Koyun
title Evaluation of the relationship between muscle mass and serum myostatin levels in chronic hemodialysis patients
title_short Evaluation of the relationship between muscle mass and serum myostatin levels in chronic hemodialysis patients
title_full Evaluation of the relationship between muscle mass and serum myostatin levels in chronic hemodialysis patients
title_fullStr Evaluation of the relationship between muscle mass and serum myostatin levels in chronic hemodialysis patients
title_full_unstemmed Evaluation of the relationship between muscle mass and serum myostatin levels in chronic hemodialysis patients
title_sort evaluation of the relationship between muscle mass and serum myostatin levels in chronic hemodialysis patients
publisher Wolters Kluwer Medknow Publications
series Saudi Journal of Kidney Diseases and Transplantation
issn 1319-2442
publishDate 2018-01-01
description The loss of muscle mass and cachexia is commonly seen in hemodialysis (HD) patients and contribute to morbidity and mortality. The exact mechanism of this fact is multifactorial and still unclear. Myostatin, a transforming growth factor-ß family ligand, is released from the skeletal and heart muscle and may be responsible for muscle degradation and atrophy. The aim of this study is evaluation of the relationship between muscle mass and serum myostatin level in chronic HD patients. One hundred and forty HD patients (79 males, 28 diabetic, mean age; 53.96 ± 13.6) were included in this cross-sectional study. Muscle mass measurement was made with dual energy-X ray absorptiometry. Appendicular skeletal muscle index (ASMI) was used as a muscle mass indicator. The anthropometric and biochemistry data were obtained. Serum myostatin levels were determined by an ELISA kit. Serum myostatin levels were elevated when compared to controls (P <0.001), but no significant correlation with ASMI was observed (P = 0.624). ASMI significantly correlated with serum creatinine (P <0.001), creatine phosphokinase (P <0.001), prealbumin (P <0.012), albumin (P <0.039), transferrin (P <0.001), phosphorus (P <0.001), Ca×P (P <0.012), inversely with Kt/V (P <0.001); not with BUN (P = 0.739), parathyroid hormone (P = 0.698), 25-hydroxyvitamin D (P = 0.603), bicarbonate (P = 0.062); such that these parameters also have influence on muscle mass regulation. Our study indicated that myostatin levels were high in HD patients but had no relation with ASMI. Myostatin is a well-known regulator of muscle mass so further studies are needed to demonstrate possible relationship.
url http://www.sjkdt.org/article.asp?issn=1319-2442;year=2018;volume=29;issue=4;spage=809;epage=815;aulast=Koyun
work_keys_str_mv AT deryakoyun evaluationoftherelationshipbetweenmusclemassandserummyostatinlevelsinchronichemodialysispatients
AT gokhannergizoglu evaluationoftherelationshipbetweenmusclemassandserummyostatinlevelsinchronichemodialysispatients
AT kemalmetinkir evaluationoftherelationshipbetweenmusclemassandserummyostatinlevelsinchronichemodialysispatients
_version_ 1725663145473605632